This Comment will review the history of strict products liability and the policies which have shaped its development. It will examine the state of the law today regarding strict liability for harm caused by prescription drugs, and demonstrate that comment k should continue to govern prescription drugs. Furthermore, it will point out that sound reasoning and public policy dictate that the modified strict products liability of comment k, rather than ordinary strict products liability, is the appropriate theory to establish liability for prescription drugs; it is also the method most beneficial to society\u27s needs. Finally, this Comment will predict how the California Supreme Court will apply comment k to prescription drugs when the court is...
This comment will demonstrate how discrepancies among product li- ability standards and different i...
Over the past two decades, courts have consistently ruled that the manufacturer of a brand-name pres...
A mere five years ago, the Food and Drug Administration (the FDA ) began, for the first time in its...
This Comment will review the history of strict products liability and the policies which have shaped...
Injuries from adverse drug reactions have increased dramatically in recent years. This increase is l...
This Comment uses the recent Paxil litigation as an example of how the rise of federal bureaucratic ...
In Brown v. Superior Court the California Supreme Court held that a drug manufacturer cannot be held...
The law of strict liability, as set forth in Section 402A of the Restatement (Second) of Torts, prov...
Part I provides a brief and basic explanation of pharmaceutical liability treatment. Part II explain...
Many have been bewitched, bedazzled, and bewildered in attempting to figure just how the principles ...
The author considers whether strict liability should be imposed for injuries caused by products that...
This Comment will discuss the inability of tort law to provide an adequate solution to this issue, a...
This note will use the principles of law and economics to examine the interaction of market structur...
Dangerous products may give rise to colossal liability for commercial actors. Indeed, in 2021, the U...
Professor Green addresses the matter of the proper balance between the tort system and regulation in...
This comment will demonstrate how discrepancies among product li- ability standards and different i...
Over the past two decades, courts have consistently ruled that the manufacturer of a brand-name pres...
A mere five years ago, the Food and Drug Administration (the FDA ) began, for the first time in its...
This Comment will review the history of strict products liability and the policies which have shaped...
Injuries from adverse drug reactions have increased dramatically in recent years. This increase is l...
This Comment uses the recent Paxil litigation as an example of how the rise of federal bureaucratic ...
In Brown v. Superior Court the California Supreme Court held that a drug manufacturer cannot be held...
The law of strict liability, as set forth in Section 402A of the Restatement (Second) of Torts, prov...
Part I provides a brief and basic explanation of pharmaceutical liability treatment. Part II explain...
Many have been bewitched, bedazzled, and bewildered in attempting to figure just how the principles ...
The author considers whether strict liability should be imposed for injuries caused by products that...
This Comment will discuss the inability of tort law to provide an adequate solution to this issue, a...
This note will use the principles of law and economics to examine the interaction of market structur...
Dangerous products may give rise to colossal liability for commercial actors. Indeed, in 2021, the U...
Professor Green addresses the matter of the proper balance between the tort system and regulation in...
This comment will demonstrate how discrepancies among product li- ability standards and different i...
Over the past two decades, courts have consistently ruled that the manufacturer of a brand-name pres...
A mere five years ago, the Food and Drug Administration (the FDA ) began, for the first time in its...